Patients should discuss potential benefits, risks, and side effects with their healthcare provider before and during treatment
The first GLP-1 receptor agonist, exenatide was approved by the FDA for the treatment of T2DM in 2005
(13) Interestingly, elevated OPG levels observed in patients with type 1 diabetes may reflect a compensatory response to increased bone turnover
Light exposure Peptides degrade faster when exposed to light, particularly UV light
Patients should understand that medication efficacy is maximized when combined with appropriate dietary modifications, and frequent fast food consumption may limit the clinical benefits they experience from GLP-1 therapy
They represent thousands of people watching their hair thin while pursuing a healthier weight, caught between the undeniable benefits of weight loss therapy and an unexpected cosmetic consequence that nobody prepared them for